Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies. | Clin Rev Allergy Immunol | 2023 | 34468946 | PubTator, text mining | PubMed |
| Diesel exhaust exposure alters the expression of networks implicated in neurodegeneration in zebrafish brains. | Cell Biol Toxicol | 2023 | 34057650 | PubTator, text mining | PubMed |
| Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014. | J Am Acad Dermatol | 2023 | 30287320 | PubTator, text mining | PubMed |
| Analysis of real-time PCR Melanocortin 3 (MC3R) gene expression to identify new biomarkers inflammation in tuberculosis. | Egypt J Med Hum Genet | 2022 | 37521838 | PubTator, text mining | PubMed |
| Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%). | Int J Trichology | 2022 | 37034550 | PubTator, text mining | PubMed |
| Melanogenesis and Hypopigmentation: The Case of Vitiligo. | Indian J Dermatol | 2022 | 36865864 | PubTator, text mining | PubMed |
| Melanocortin therapies to resolve fibroblast-mediated diseases. | Front Immunol | 2022 | 36793548 | PubTator, text mining | PubMed |
| Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation. | Glomerular Dis | 2022 | 36751532 | PubTator, text mining | PubMed |
| Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment. | Pharmaceutics | 2022 | 36678756 | PubTator, text mining | PubMed |
| The Potential of Purple Waxy Corn Cob (Zea mays L.) Extract Loaded-Sericin Hydrogel for Anti-Hyperpigmentation, UV Protection and Anti-Aging Properties as Topical Product Applications. | Pharmaceuticals (Basel) | 2022 | 36678532 | PubTator, text mining | PubMed |
| Disease-Gene Networks of Skin Pigmentation Disorders and Reconstruction of Protein-Protein Interaction Networks. | Bioengineering (Basel) | 2022 | 36671585 | PubTator, text mining | PubMed |
| Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand? | Front Med (Lausanne) | 2022 | 36619636 | PubTator, text mining | PubMed |
| Revisiting the Role of Local Cryotherapy for Acne Treatment: A Review and Update. | J Clin Med | 2022 | 36614827 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis. | Int J Mol Sci | 2022 | 36614041 | PubTator, text mining | PubMed |
| A Skeletal Muscle-Centric View on Time-Restricted Feeding and Obesity under Various Metabolic Challenges in Humans and Animals. | Int J Mol Sci | 2022 | 36613864 | PubTator, text mining | PubMed |
| The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin. | Int J Mol Sci | 2022 | 36613652 | PubTator, text mining | PubMed |
| Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS. | Cancers (Basel) | 2022 | 36612224 | PubTator, text mining | PubMed |
| Genetic Diversity Relationship in Azakheli Buffalo Inferred from mtDNA and MC1R Sequences Comparison. | Biomed Res Int | 2022 | 36601617 | PubTator, text mining | PubMed |
| Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. | Front Immunol | 2022 | 36591255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=25